Freedom Broker cuts General Mills stock price target on cost pressures

General Mills reported fiscal Q4 2026 adjusted EPS of $0.95 vs $0.81 consensus and revenue of $4.6B vs $4.58B, but analysts remained divided. Freedom Broker cut its GIS price target to $42 (from $70) and kept Hold as the consumer backdrop, higher costs, and slower category growth weighed on the outlook, with guidance for fiscal 2027 described as slightly below consensus for organic sales/adjusted EBIT. Other firms leaned bullish (Stifel Buy to $40), while Wells Fargo lifted its target to $33 (Underweight) citing an improved inflation outlook and TD Cowen raised to $32 (Hold). The stock’s ~6.46% dividend yield and 56 straight years of dividend payments were highlighted amid the mixed earnings-to-outlook reaction.

Analysis

GIS reads as a classic defensive cash-flow story, but the market is unlikely to pay up until there is evidence that volume is turning, not just margins. The key mechanism is that cost savings can bridge EPS for a few quarters, yet sustained multiple expansion requires category share gains; without that, the stock behaves like an income bond with equity risk, which caps upside despite the dividend floor.

Second-order, the pressure point is not just consumers trading down but retailers flexing own-label leverage. That favors private-label-heavy operators and can keep branded-packaged-food pricing power weak; if the consumer stays soft, TGT-style assortment decisions may keep siphoning demand away from branded aisles, delaying any organic-sales recovery for 1-3 quarters. WFC is a slower-burn read-through: if job softness deepens, deposit costs may ease, but delinquency and revolving-credit stress would eventually hit discretionary spend before it helps staples volumes.

The contrarian view is that the analyst spread is really a disagreement on whether the earnings beat was durable or just inflation accounting and cost actions. Consensus may be underweighting the downside if FY27 organic sales stay subtrend; in that case the stock can stay cheap for months even with a 6%+ yield. Falsifier: a clean two-quarter run of positive volume/share, or management guiding to sustained organic growth above current street numbers; absent that, the base case is range-bound trading with downside limited by income buyers, not a true rerating.

Key Decisions for Investors

• GIS: do not chase here; only add on a pullback toward the low-$30s if scanner/IRI data confirm stabilization in volumes. Target is yield support plus a modest rerating over 6-12 months; thesis breaks if organic sales re-accelerate in the next print.
• Pair trade for a mild risk-off tape: long GIS / short TSLA for 1-3 months. The idea is defensive cash flow versus high-duration multiple compression; cover the short if real yields fall sharply and TSLA reclaims prior highs on macro relief.
• For income mandates, consider selling cash-secured GIS puts only at strikes where you are comfortable owning the stock into the low-$30s. The carry works, but exit if FY27 guidance is revised lower on organic sales or EBIT.
• Watch TGT private-label and basket data as the key second-order indicator. If trade-down accelerates, keep a relative overweight to branded staples like GIS versus discretionary retail; if it eases, the valuation floor on GIS weakens.